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FIG. 1. Integrin expression in MV3 transfectants.
(MV3-neo), or with pBJlneo including ¡33 cDNA followed by bulk sorting with LM609 avj33 mAb 
Shown is the relative fluorescence after incubation with mAbs to i 
second antibody.
Transfection. Full-length cDNA for the integrin ¡33 subunit [14], from Dr. Erkki Ruoslahti (La Jolla, CA), was
% »
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cloned in the polylinker of the mammalian expression vector pBJlneo [15], from Dr.
Jolla, CA). Twenty /xg of this construct was used for stable transfection of MV3 cells according to the calcium 
phosphate precipitation method [16]. Stably transfected cells were selected in the presence of 1 mg/ml G418 (Life 
Technologies) and bulk sorted with LM609 mAb on an Epics flowcytometer (Coulter, Mijdrecht, The Netherlands).
Flow cytometry. Cells were incubated sequentially with mAbs and fluorescein-isothiocyanate (FITC)-labeled F(ab')2 
fragments of rabbit anti-mouse Ig antibodies (Dako, Glostrup, Denmark) for 30 min at 4°C, and fluorescence was 
measured on an Epics flowcytometer (Coulter).
Cell adhesion assay. Polystyrene microtiter plates (Greiner, Alphen a/d Rijn, The Netherlands) were coated overnight 
at 4°C with the appropriate adhesive ligands, and blocked for lh at 37°C with 0.5% BSA. Subsequently, 1x10  
labeled MV3 cells in 50 ¡A DMEM/Q.5% BSA were added to the wells and incubated for 30 min at 37°C in 5% C 02. 
Unbound cells were washed out, bound cells were lysed, and radioactivity of the lysate was measured. Results are 
presented as the mean percentage of cell binding from triplicate wells. For adhesion inhibition studies, cells were 
preincubated with the appropriate mAbs for 30 min at 4°C before seeding into the wells.
Invasion assay. Matrigel-coated 8/u.m pore filters (24 wells; Becton Dickinson, Bedford, MA) were preincubated 
with serum-free medium for 2 h at 37°C. Subsequently, 900 fi\ complete medium was added to the lower compartment 
and 1x10s cells in 200 fA serum-free medium were added to the upper compartment. Filters were incubated for 48h 
at 37°C. For visual inspection, filters were fixed in 2% glutaraldehyde, cells were scraped from the upper surface, 
filters were washed with PBS, incubated for 15 min in Mayers hematoxylin, washed, and scored by light microscopy.
For semiquantitative analysis [17], cells were scraped from the upper surface, filters were washed with PBS, and 
incubated for 4h at 37°C in 0.5 mg/ml 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tétrazolium bromid (MTT; Sigma). 
Subsequently, purple formazan crystals formed in active mitochondria were solubilized in 10% SDS in 0.01 M HC1 
o/n at 37°C. Absorbance of the solutions was measured at 540 nm with a 690 nm reference wavelength.
Tumorigenicity and experimental metastasis assay. For tumorigenesis, 2 x l0 6 tumor cells in 
were subcutaneously (s.c.) inoculated and tumor volume was measured weekly. For lung colonization, 2 x l0 ft tumor 
cells in 200 ¡A 0.9% NaCl were intravenously (i.v.) inoculated into the lateral tail vein, mice were killed 
month, lungs were formalin fixed and embedded in paraffin, and H&E-stained 4 /¿m sections from 3 different levels
ies. In our experience, no other organs are colonized [13]. 
Statistical analysis. Fisher’s Exact Test (two-sided) was used for comparison of percentages of mice that developed
RESULTS
it expressed other av integrins including av/35 (Fig 1). The 
expression pattern was not altered in MV3-neo whereas MV3-/53 expressed av/33 at the 
surface. Total av-staining was not affected but the level of av/35 was decreased, indicating 
that ¡33 competed with (35 for association with the av subunit. No changes were observed in 
the level of expression of ¡3 1 (Fig 1) or any other integrin subunit (including a 1-6, allb, /?2, 
/34, /?8; not shown). MV3-/?3 but not MV3 or MV3-neo adhered to Fg- or GRGDSP-coated
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FIG. 3. Inhibition of adhesion of MV3-/?3 with anti-a:v/?3 mAb. MV3-/33 cells were allowed to adhere to wells 
coated with 25 /¿g/ml BSA-GRGDSP or Fg in the absence or presence of LM609 anti-av/?3 or P1F6 anti-av/?5
function blocking mAbs. Mean ± s.d. from triplicate determinations is shown for 1 experiment of 3
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FIG. 5. Effect of av/?3 on invasion of MV3 cells. Absorbance of samples from MV3 cells that invaded through 
matrigel-coated or migrated through uncoated filters was measured. This control value (c) was normalized to 100% 
and the relative migratory/invasive potential of MV3~neo and MV3-/?3 cells is shown. Mean ±  s.d. of duplicate 
determinations of 1 of 2 experiments is shown.
causal role for av/33 in melanoma metastasis in mice. Parenthetically, av/33 on endothelial 
cells is crucial for angiogenesis in melanomas [29], and thus, in a more indirect manner, for 
melanoma growth.
The fact that MV3 is highly tumorigenic and metastatic while it lacks aw(33 [7,13] seems 
surprising, but it confirms earlier reports of melanoma cell lines that grow and metastasize in 
the absence of this integrin [6,8], Together, these reports demonstrate that av/33 may be 
important for growth, invasion, and metastasis of some melanoma cell lines, but that other 
melanoma cell lines use alternative mechanisms that do not involve this integrin. Moreover,
downmodulation of av/33 expression has been shown to enhance A375m melanoma cell 
invasiveness in vitro [8], indicating that av/33 can actually inhibit invasion of some cell lines. 
Our finding that av/33 expression in MV3 reduces its in vitro invasive capacity as well as its 
ability to form lung colonies upon i.v. inoculation into nude mice, extends this finding.
Cell line
MV3
MV3-neo
MV3-/33
TABLE 1
Experimental Metastasis of MV3, MV3-neo, and MV3-
MM
Number o f  mice with lung colonies/number of mice inoculated
Exp. 1 Exp. 2 Exp. 3 Total %
3/5" 4/5 4/5 11/15 73
2/5 3/4 4/5 9/14 64
0/5 0/5 0/5 0/15 A
AMP
P
Vol. 226. No BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
We do not know how av/33 inhibits MV3 invasion and experimental metastasis. As we 
have no evidence for a role for av¡35 in the adhesive phenotype of MV3 (av/35 is not involved 
in MV3 adhesion to Fn [30] and we could not detect MV3 adhesion to vitronectin (not shown), 
Fg, or RGD), loss of the low surface expression of av/35 is unlikely to be responsible for the 
observed changes in behavior of MV3, though we cannot absolutely rule this out.
Firm av/33-mediated adhesion to Fn may overrule /31 integrin-mediated interactions 
Fn involved in cell migration [31]. Alternatively, av/33 signaling may affect the function of 
other integrins, and as a result interfere with invasive behavior. Our finding that the acquired 
adhesion of MV 3-/33 to RGD and Fg is not completely blocked by the LM609 anti-av/?3 
mAb,
line to RGD and Fg), have become activated in MV3-/33. In addition, av/33 expression may
interfere the complex of signals derived from other integrins that regulates protease
hypotheses, it is important to
in our experiments, av/33 expression is forced onto cells that have adopted a strategy for 
invasion and metastasis in the absence of this integrin. In such a cellular background (integrin/ 
protease profile, etc.) av/33 may be obstructive while it may be part of the metastatic design 
in other melanoma cells.
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